| Name | 2-(Hydroxymethyl)pyrimidine | 
|---|---|
| Synonyms | 
                                
                                pyrazin-2-ylmethanol
                                
                                
                                 2-Pyrimidine-methanol 2-(Hydroxymethyl)pyrazine T6N DNJ B1Q MFCD06796201 2-Pyrimidinemethanol 2-Pyrimidinylmethanol 2-Pyrazinylmethanol 2-Pyrazinemethanol hydroxymethylpyrimidine Pyrimidin-2-ylmethanol  | 
                        
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Boiling Point | 198.2±23.0 °C at 760 mmHg | 
| Molecular Formula | C5H6N2O | 
| Molecular Weight | 110.114 | 
| Flash Point | 73.7±22.6 °C | 
| Exact Mass | 110.048012 | 
| PSA | 46.01000 | 
| LogP | -0.85 | 
| Vapour Pressure | 0.2±0.4 mmHg at 25°C | 
| Index of Refraction | 1.557 | 
| Hazard Codes | F+ | 
|---|---|
| RIDADR | 1993.0 | 
| HS Code | 2933599090 | 
| 
                                
                                
                                
                                
                                
                                
                                 ~37%  
                                    42839-09-8  | 
                        
| Literature: THERACRINE, INC.; SUN, Lijun; BARSOUM, James; WESTER, Ronald Patent: WO2013/13238 A2, 2013 ; Location in patent: Page/Page column 33 ; | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    42839-09-8  | 
                        
| Literature: Smith Kline and French Laboratories Limited Patent: US3950333 A1, 1976 ; US 3950333 A | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    42839-09-8  | 
                        
| Literature: ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew, J.; BURSAVICH, Matthew, Gregory Patent: WO2013/142269 A1, 2013 ; | 
| Precursor 3 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 | 
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |